Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

LABORATÓRIO EDOL - PRODUTOS FARMACÊUTICOS S.A.

NIF 507072642
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €4,495,036 79 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €4,495,036 79 contracts
A2 · Late Publication €7,102,235,609 1,265 contracts
Contract published to BASE more than 10 days after the signing date
LOW €7,102,235,609 1,265 contracts
A5 · Threshold Splitting €2,716,196 46 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €2,716,196 46 contracts
A6 · Low Competition €117,729 2 contracts
Only one bidder participated in a competitive procedure
MEDIUM €117,729 2 contracts
A9 · Price Overrun €397 2 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
HIGH €99 1 contracts
MEDIUM €298 1 contracts
A9 · Abnormal Price Reduction €8,830,440,046 707 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €8,830,440,046 707 contracts
B5 · Benford's Law Deviation €630,460,246 2 contracts
Entity's contract values deviate from the Benford leading-digit distribution (chi-square goodness-of-fit, min 20 contracts). Score: 35 (p<0.05) or 55 (p<0.01).
MEDIUM €630,460,246 2 contracts
C3 · Missing Mandatory Fields €219,154 19 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €219,154 19 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

122
€632,643,742
9
€354,228,368
10
€353,455,232
39
€345,606,726
7
€345,444,690
23
€344,414,409
36
€344,265,948
8
€343,643,395
134
€338,951,680
30
€323,539,007
43
€322,158,085
54
€318,279,399
68
€317,486,418
183
€317,302,520
12
€317,137,135
49
€316,722,747
14
€316,436,221
16
€316,291,760
18
€316,036,602
35
€315,994,482
Page 1 of 4 · 65 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Price Overrun A9 · Abnormal Price Reduction B5 · Benford's Law Deviation C3 · Missing Mandatory Fields

Page 1 of 1 · 19 contracts

Aquisição de Kit Cir. Pos OP OFT (Dexametasona+Ofloxacina+Cetorolac) 1 mg/ml+3 mg/ml+5 mg/ml
PT · 11728381 · Concurso público
C3 · Missing Mandatory Fields A6 · Low Competition
€105,480 2024-12-26
4180023/2025 - AQ 2024/782 - Medicamentos usados em afeções oculares e otorrinolaringológicas
PT · 11443226 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€7,616 2024-12-23
MEDICAMENTOS
PT · 11512861 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€2,408 2024-12-18
PQ/171/2025
PT · 11602622 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€860 2024-12-16
AE/108/2025 - MEDICAMENTOS EXCLUSIVOS EDOL
PT · 11294654 · Ajuste Direto Regime G...
C3 · Missing Mandatory Fields
€8,105 2024-12-11
PQ/3370/2024 - OXIDO ZINCO 6% SUSP AQ CUTANEA _ CPA 671/2023
PT · 11304072 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€410 2024-12-09
Prednisolona
PT · 11227989 · Ajuste Direto Regime G...
C3 · Missing Mandatory Fields
€128 2024-12-09
MEDICAMENTOS PARA TRATAMENTO DE AFEÇÕES OCULARES
PT · 11277502 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€36,010 2024-11-20
31/149/2025 - Medicamentos "Oxibuprocaína e Oxitetraciclina"
PT · 11238599 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€2,304 2024-11-14
MEDICAMENTOS DIVERSOS AQ 2024/782
PT · 11281787 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€11,941 2024-10-02
13000022962024
PT · 11243088 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€7,770 2024-08-29
Aquisição de Medicamentos Diversos ao abrigo de vários Acordos Quadro, AQ 21/2020, 55/2021, 61/2021, 40/2022,55/2022, 173/2022 E 481/2023.
PT · 11235535 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€2,284 2024-08-07
PREDNISOLONA 5 MG/G POM OFT BISN 5G
PT · 11181295 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€688 2024-07-22
Aquisição de Oxido de zinco + Amido (pomada) 250g] AQ 2023/490
PT · 11294458 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€688 2024-05-31
Aquisição de Medicamentos Diversos (CP 2022/55)
PT · 11348289 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€149 2024-05-17
OXIBUPROCAÍNA 4 MG/ML COL, SOL FR 10 ML
PT · 11221619 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€10,036 2024-03-01
PQ/679/2024 -MED.USADOS EM EFFECÇÕES CUTANEAS
PT · 11532247 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€275 2024-02-22
Aquisição de Medicamentos Diversos SPMS 2021/55
PT · 11224641 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€9,180 2024-01-29
MEDICAMENTOS DIVERSOS
PT · 11244294 · Ajuste Direto Regime G...
C3 · Missing Mandatory Fields
€12,817 2024-01-19
Overview
Total Value Won
€8,850,485,125
Contracts Won
1,810
Score 63845 · CRITICAL RISK
NIF
507072642
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • C.D. [P-c296]
    Presidente
    since 2011-04-15
  • C.D. [P-c296]
    Presidente
    since 2014-04-22
  • C.D. [P-c296]
    Presidente
    since 2019-10-31
  • C.D. [P-c296]
    Presidente
    since 2020-11-15
  • E.J. [P-13b7]
    Vogal
    since 2025-06-25
  • G.T. [P-7a5b]
    Vogal
    since 2014-04-22
  • G.T. [P-7a5b]
    Vogal
    since 2019-10-31
  • G.T. [P-7a5b]
    Vogal
    since 2020-11-15
  • J.L. [P-2fc2]
    Vogal
    since 2025-06-25
  • M.L. [P-ec28]
    Administrador
    since 2011-04-15
  • M.L. [P-ec28]
    Vogal
    since 2011-06-30
  • M.J. [P-7a5a]
    Presidente
    since 2025-06-25
  • M.P. [P-4ecf]
    Administrador
    since 2011-04-15
  • M.P. [P-4ecf]
    Vogal
    since 2014-04-22
  • M.P. [P-4ecf]
    Vogal
    since 2019-10-31
  • M.P. [P-4ecf]
    Vogal
    since 2020-11-15
  • R.M. [P-19df]
    Vogal
    since 2011-06-30
  • B.A. [P-f99d]
    Fiscal Único
    since 2011-04-15
  • B.A. [P-f99d]
    Fiscal Único
    since 2014-04-22
  • B.A. [P-f99d]
    Fiscal Único
    since 2019-10-31
  • B.A. [P-f99d]
    Fiscal Único
    since 2020-11-15
  • B.A. [P-f99d]
    Fiscal Único
    since 2023-08-17
  • J.G. [P-c022]
    Fiscal Único
    since 2011-04-15
  • J.G. [P-c022]
    Fiscal Único
    since 2014-04-22
  • M.R. [P-f21c]
    Fiscal Único
    since 2019-10-31
  • M.R. [P-f21c]
    Fiscal Único
    since 2020-11-15
  • P.A. [P-274b]
    Fiscal Único
    since 2023-08-17
  • C.D. [P-c296]
    Presidente
    2023-08-17 → 2025-06-25
  • G.T. [P-7a5b]
    Vogal
    2023-08-17 → 2025-06-25
  • M.P. [P-4ecf]
    Vogal
    2023-08-17 → 2025-06-25
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned